Aqilion to present results at scientific events
AQILION AB (publ) will present updates on the Company's progress and scientific results at two different scientific conferences in May. The presentations will cover the pipeline programs AQ280 for the treatment of eosinophilic esophagitis and AQ312 for the treatment of ulcerative colitis.Johan Lund, CSO, will present Aqilion's pipeline with a special focus on the pipeline programs AQ280 and AQ312 at the 20th Annual Conference of International Drug Discovery and Science technology (IDDST) in Osaka, Japan, May 22-24, . Anneli Tinnerholm,